A randomized controlled trial was conducted from November 2015 and May 2016 with 112 participants of people diagnosed with schizophrenia. Participants aged 18 years or older with Diagnostic Statistical Manual (DSM-V) schizophrenia or schizoaffective disorder from outpatient mental health clinics in Jordan, were randomly assigned participants either to receive 6 weeks of a booklet form of intervention with face to face discussion, and treatment as usual (TAU) (intervention, n = 56), or TAU (control, n = 56). Participants were assessed at baseline, immediately post-intervention (post-treatment1) and at three months follow-up. The primary outcome measure was change in helplessness score . Secondary outcomes for PDwS were psychiatric symptoms, recovery rate and quality of life.
A randomized controlled trial was conducted from November 2015 and May 2016 with 112 participants of people diagnosed with schizophrenia. Participants aged 18 years or older with DSM-V schizophrenia or schizoaffective disorder from outpatient mental health clinics in Jordan, were randomly assigned participants either to receive 6 weeks of a booklet form of intervention with face to face discussion, and treatment as usual \[TAU\] (intervention, n = 56), or TAU (control, n = 56). Participants were assessed at baseline, immediately post-intervention (post-treatment1) and at three months follow-up. The primary outcome measure was change in helplessness score . Secondary outcomes for PDwS were psychiatric symptoms, recovery rate and quality of life.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Enrollment
102
6 weeks of empowerment program and supported face to face discussion
Modified Learned Helplessness
Outcome was measured at baseline (November) and immediately post intervention (February) and at three months follow up (May)
Time frame: Up to 6 months
Psychiatric symptoms
Outcome was measured at baseline (November) and immediately post intervention (February) and at three months follow up (May)
Time frame: Up to 6 months
recovery assessment scale
Outcome was measured at baseline (November) and immediately post intervention (February) and at three months follow up (May)
Time frame: Up to 6 months
Empowerment level
Outcome was measured at baseline (November) and immediately post intervention (February) and at three months follow up (May)
Time frame: Up to 6 months
Quality of life
Outcome was measured at baseline (November) and immediately post intervention (February) and at three months follow up (May)
Time frame: Up to 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.